FDA Inspection 934717 — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited — FEI 3006611178

The FDA completed an inspection of Takeda Pharmaceutical Company Limited on July 9, 2015 in Ammon, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 9, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ammon, ID (United States)